Jianfeng Pharmaceutical passed the national high-tech enterprise identification for the fourth time.


Release time:

2018-01-12

A few days ago, the Office of the National Leading Group for the Accreditation and Management of High-tech Enterprises announced the list of the first batch of high-tech enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical was listed among them, and was awarded by the Zhejiang Provincial Department of Science and Technology, Zhejiang Provincial Department of Finance, and Zhejiang Provincial State The "High-tech Enterprise Certificate" jointly issued by the Taxation Bureau and Zhejiang Local Taxation Bureau ". This is also the fourth consecutive time that Jianfeng Pharmaceutical has passed the national high-tech enterprise certification since 2008.

A high-tech enterprise refers to an enterprise registered in China (excluding Hong Kong, Macao and Taiwan) for more than one year by continuously carrying out research and development and transformation of technological achievements in the high-tech fields supported by the state, forming the core independent intellectual property rights of the enterprise, and carrying out business activities on this basis. The selection of high-tech enterprises is based on the core independent intellectual property rights, products or services belonging to the scope of high-tech fields, the proportion of enterprise scientific and technological talents, research and development costs, enterprise innovation ability, scientific and technological achievements transformation ability, growth indicators and other indicators for comprehensive scoring. The identification criteria are very strict. In June 2016, the Ministry of Science and Technology, the Ministry of Finance and the State Administration of Taxation revised and issued the 2016 version of the guidelines for the Identification and Management of High-tech Enterprises, which made substantial adjustments to the identification conditions and other contents. in particular, the identification standards for the R & D and innovation management of enterprises have been improved, and the "threshold" for the identification of high-tech enterprises has been greatly raised. To this end, Jianfeng Pharmaceutical has prepared corresponding personnel, materials and systems in advance. According to the requirements of the new regulations, it has collected effective and accurate materials, extracted and written application materials, and laid a good foundation for one-time identification.

High-tech enterprise is a special qualification recognized by the state to support and encourage the development of high-tech enterprises, adjust the industrial structure and enhance the national economic competitiveness. It is the only state-level enterprise qualification, which occupies a very important strategic position in China's economic development. It is recognized that enterprises generally have high growth and high economic benefits, which is an indispensable hard signboard for enterprises relying on science and technology. As a high-tech enterprise, it can enjoy certain preferential policies in tax reduction and exemption, special fund declaration, bidding, government procurement, etc. Through this determination, Jianfeng Pharmaceutical will enjoy the preferential income tax policy for high-tech enterprises within three years from 2017 (January 1, 2017 to December 31, 2019), that is, to pay enterprise income tax at a tax rate of 15%.